These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 23580529)

  • 1. Persistent LCMV infection is controlled by blockade of type I interferon signaling.
    Teijaro JR; Ng C; Lee AM; Sullivan BM; Sheehan KC; Welch M; Schreiber RD; de la Torre JC; Oldstone MB
    Science; 2013 Apr; 340(6129):207-11. PubMed ID: 23580529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of chronic type I interferon signaling to control persistent LCMV infection.
    Wilson EB; Yamada DH; Elsaesser H; Herskovitz J; Deng J; Cheng G; Aronow BJ; Karp CL; Brooks DG
    Science; 2013 Apr; 340(6129):202-7. PubMed ID: 23580528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.
    Lee MS; Park CH; Jeong YH; Kim YJ; Ha SJ
    PLoS Pathog; 2013; 9(7):e1003478. PubMed ID: 23874199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interfering with type I interferon: a novel approach to purge persistent viral infection.
    Wilson EB; Brooks DG
    Cell Cycle; 2013 Sep; 12(18):2919-20. PubMed ID: 23974094
    [No Abstract]   [Full Text] [Related]  

  • 5. Slow viral propagation during initial phase of infection leads to viral persistence in mice.
    Xu HC; Wang R; Shinde PV; Walotka L; Huang A; Poschmann G; Huang J; Liu W; Stühler K; Schaal H; Bergthaler A; Pandyra AA; Hardt C; Lang KS; Lang PA
    Commun Biol; 2021 Apr; 4(1):508. PubMed ID: 33927339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
    Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
    J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.
    Osokine I; Snell LM; Cunningham CR; Yamada DH; Wilson EB; Elsaesser HJ; de la Torre JC; Brooks D
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7409-14. PubMed ID: 24799699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection: the interferon paradox.
    Papatriantafyllou M
    Nat Rev Immunol; 2013 Jun; 13(6):392. PubMed ID: 23648970
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. An interferon paradox.
    Odorizzi PM; Wherry EJ
    Science; 2013 Apr; 340(6129):155-6. PubMed ID: 23580520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved and Differential Features of TNF Superfamily Ligand Expression on APC Subsets over the Course of a Chronic Viral Infection in Mice.
    Wang KC; Chu KL; Batista NV; Watts TH
    Immunohorizons; 2018 Dec; 2(11):407-417. PubMed ID: 31026809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.
    Montoya M; Edwards MJ; Reid DM; Borrow P
    J Immunol; 2005 Feb; 174(4):1851-61. PubMed ID: 15699111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity.
    McAfee MS; Huynh TP; Johnson JL; Jacobs BL; Blattman JN
    Virology; 2015 Oct; 484():153-162. PubMed ID: 26099694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection.
    Wang Y; Swiecki M; Cella M; Alber G; Schreiber RD; Gilfillan S; Colonna M
    Cell Host Microbe; 2012 Jun; 11(6):631-42. PubMed ID: 22704623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestasis induced liver pathology results in dysfunctional immune responses after arenavirus infection.
    Lang E; Pozdeev VI; Shinde PV; Xu HC; Sundaram B; Zhuang Y; Poschmann G; Huang J; Stühler K; Pandyra AA; Keitel V; Häussinger D; Lang KS; Lang PA
    Sci Rep; 2018 Aug; 8(1):12179. PubMed ID: 30111770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
    Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
    PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.
    Belnoue E; Fontannaz P; Rochat AF; Tougne C; Bergthaler A; Lambert PH; Pinschewer DD; Siegrist CA
    PLoS One; 2013; 8(12):e85302. PubMed ID: 24376875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.